Clune & Associates, Ltd. Abbott Laboratories Transaction History
Clune & Associates, Ltd.
- $326 Billion
- Q1 2025
A detailed history of Clune & Associates, Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Clune & Associates, Ltd. holds 14,917 shares of ABT stock, worth $1.97 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
14,917
Previous 14,541
2.59%
Holding current value
$1.97 Million
Previous $1.64 Billion
20.31%
% of portfolio
0.61%
Previous 0.55%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,545Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$22.5 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.3 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.84 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.71 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $232B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...